Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dioxybenzone is an organic compound and a derivative of benzophenone used as a sunscreen agent. It functions as a chemical UV filter by absorbing UV-B and short-wave UV-A (UVA-II) rays, thereby limiting their penetration into human skin. Approved for use in concentrations up to 3%, dioxybenzone is insoluble in water but moderately soluble in ethanol and isopropanol, contributing to the "waterproof" claims of some sunscreens. Its mechanism of action involves direct absorption of harmful ultraviolet radiation, providing photoprotection against sunburn and photoaging. There is evidence from animal models that it may also exhibit chemopreventive activity against skin carcinogenesis correlated with antioxidant potency. While some related benzophenones have weak estrogenic effects environmentally, this has not been established for dioxybenzone[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dioxybenzone.